Full Press Release Details
Opus Genetics Inherited Retinal Disease Programs Featured at Medical and Industry Conferences in September.
IRD
Opus Genetics Inherited Retinal Disease Programs Featured at Medical and Industry Conferences in September
Key Takeaway: Opus Genetics Inherited Retinal Disease Programs Featured at Medical and Industry Conferences in September
Price reaction · baseline $1.205 (2025-08-26 close) · hit after-hours · 1 other IRD headline(s) in the window, move may be shared
day 0 close
-0.4%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+140%
120-day peak, hindsight
Typical move
6.3%
average across 11 past catalysts
Cash runway
~22 mo
Low dilution risk
Lead asset
APX3330
Phase 2 · Diabetic Retinopathy